miR-375 mediated acquired chemo-resistance in cervical cancer by facilitating EMT.
miR-375 mediated acquired chemo-resistance in cervical cancer by facilitating EMT.
复制标题
miR-375 通过促进 EMT 介导宫颈癌获得性化疗耐药
DOI:
10.1371/journal.pone.0109299
复制
发表时间:
2014
期刊:
影响因子:
3.7
通讯作者:
Cheng X
中科院分区:
文献类型:
--
作者:
Shen Y;Zhou J;Li Y;Ye F;Wan X;Lu W;Xie X;Cheng X
Acquired chemo-resistance is one of the key causal factors in cancer death. Emerging evidences suggest that miRNA and epithelial–mesenchymal transition play critical roles in the chemo-resistance in cancers. Here, we showed the association of paclitaxel-resistance with miR-375 over-expression and epithelial–mesenchymal transition inducement in cervical cancer. Using different cervical cancer cell models, we found that paclitaxel transiently induced up-regulation of miR-375 expression, proliferation inhibition, transition from epithelial to mesenchymal phenotype, and consequently impaired paclitaxel sensitivity. Forced over-expression of miR-375 may suppress Ecadherin expression by a directly targeting pathway, which led to paclitaxel resistance. Contrarily, re-expression of Ecadherin partly reversed epithelial–mesenchymal transition phenotype and miR-375 induced paclitaxel-resistance. Our findings suggest that paclitaxel-induced miR-375 over-expression facilitates epithelial–mesenchymal transition process via directly targeting Ecadherin, proliferation inhibition, and consequently results in chemo-resistance in cervical cancer cells. A reversion of miR-375 or Ecadherin expression may be a novel therapeutic approach for overcoming chemo-resistance in cervical cancer.
登录
查看更多内容
影响因子:
11.5
作者:
Rosano, Laura;Cianfrocca, Roberta;Bagnato, Anna
通讯作者:
Bagnato, Anna
影响因子:
8.4
作者:
Eisenhauer, E. A.;Therasse, P.;Verweij, J.
通讯作者:
Verweij, J.
影响因子:
8
作者:
Ward, A.;Balwierz, A.;Sahin, Oe
通讯作者:
Sahin, Oe
影响因子:
8.8
作者:
通讯作者:
--
影响因子:
3.7
作者:
Li, Yiwei;Kong, Dejuan;Wang, Zhiwei;Sarkar, Fazlul H.
通讯作者:
Sarkar, Fazlul H.